Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice

Madka, Venkateshwar, Zhang, Yuting, Li, Qian, Mohammed, Altaf, Sindhwani, Puneet, Lightfoot, Stan, Wu, Xue-Re, Kopelovich, Levy, Rao, Chinthalapally V·2013·Neoplasia
DOI 10.1593/neo.13704
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1593/neo.13704

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 46

  1. Schalken, 1992, Critical review of the models to study the biologic progression of bladder cancer, Semin Surg Oncol, 8, 274, 10.1002/ssu.2980080505 · doi:10.1002/ssu.2980080505
  2. Steinberg, 1992, Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment, Urol Clin North Am, 19, 735, 10.1016/S0094-0143(21)00444-4 · doi:10.1016/s0094-0143(21)00444-4
  3. Spruck, 1994, Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res, 54, 784
  4. Wagner, 1995, Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder, Hum Pathol, 26, 970, 10.1016/0046-8177(95)90086-1 · DOI
  5. Foster, 1999, Pharmacological rescue of mutant p53 conformation and function, Science, 286, 2507, 10.1126/science.286.5449.2507 · DOI · Paper page
  6. Wang, 2008, Restoration of p53 to limit tumor growth, Curr Opin Oncol, 20, 90, 10.1097/CCO.0b013e3282f31d6f · DOI
  7. Wiman, 2007, Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy, Adv Cancer Res, 97, 321, 10.1016/S0065-230X(06)97014-6 · DOI
  8. Tang, 2007, CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice, J Clin Invest, 117, 3753, 10.1172/JCI32481 · DOI · Paper page
  9. Rao, 2008, Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice, Cancer Res, 68, 7670, 10.1158/0008-5472.CAN-08-1610 · DOI · Paper page
  10. Rao, 2009, Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats, Cancer Res, 69, 8175, 10.1158/0008-5472.CAN-09-1377 · DOI
  11. Zhang, 1999, Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma, Cancer Res, 59, 3512
  12. Ahuja, 2005, SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation, Oncogene, 24, 7729, 10.1038/sj.onc.1209046 · DOI · Paper page
  13. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  14. Gandini, 2008, Tobacco smoking and cancer: a meta-analysis, Int J Cancer, 122, 155, 10.1002/ijc.23033 · DOI · Paper page
  15. Rink, 2012, Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer, Eur Urol, 63, 724, 10.1016/j.eururo.2012.08.025 · DOI
  16. Prout, 1997, Bladder carcinoma and a TNM system of classification, J Urol, 117, 583, 10.1016/S0022-5347(17)58544-4 · doi:10.1016/s0022-5347(17)58544-4
  17. Grippo, 2000, Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model, Am J Pathol, 157, 805, 10.1016/S0002-9440(10)64594-4 · doi:10.1016/s0002-9440(10)64594-4
  18. Choi, 2013, CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder, Int J Urol, 20, 251, 10.1111/j.1442-2042.2012.03128.x · DOI
  19. Cohen, 1998, Urinary bladder carcinogenesis, Toxicol Pathol, 26, 121, 10.1177/019262339802600114 · doi:10.1177/019262339802600114
  20. Grubbs, 2000, Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats, Cancer Res, 60, 5599
  21. Vinh, 2002, Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice, Jpn J Cancer Res, 93, 42, 10.1111/j.1349-7006.2002.tb01199.x · DOI
  22. Sato, 2003, Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves, Int J Urol, 10, 160, 10.1046/j.1442-2042.2003.00587.x · doi:10.1046/j.1442-2042.2003.00587.x
  23. Tyagi, 2007, Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice, Mol Cancer Ther, 6, 3248, 10.1158/1535-7163.MCT-07-2006 · DOI
  24. Lubet, 2008, Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl-(butyl)nitrosamine-induced urinary bladder cancers, Int J Cancer, 123, 2254, 10.1002/ijc.23765 · DOI
  25. Fragoso, 2012, Inhibition of mouse urinary bladder carcinogenesis by acai fruit (Euterpe oleraceae Martius) intake, Plant Foods Hum Nutr, 67, 235, 10.1007/s11130-012-0308-y · doi:10.1007/s11130-012-0308-y
  26. Green, 2001, 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice, Cancer Res, 61, 7449
  27. Perez-Stable, 2002, The Gγ/T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089, Cancer Epidemiol Biomarkers Prev, 11, 555
  28. Baratin, 2001, Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-γ delivery is associated with macrophages recruitment and nitric oxide production, Cancer Gene Ther, 8, 193, 10.1038/sj.cgt.7700285 · doi:10.1038/sj.cgt.7700285
  29. Parangi, 1996, Antiangiogenic therapy of transgenic mice impairs de novo tumor growth, Proc Natl Acad Sci USA, 93, 2002, 10.1073/pnas.93.5.2002 · DOI · Paper page
  30. Bergers, 2000, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat Cell Biol, 2, 737, 10.1038/35036374 · DOI · Paper page
  31. Degraff, 2013, Current preclinical models for the advancement of translational bladder cancer research, Mol Cancer Ther, 12, 121, 10.1158/1535-7163.MCT-12-0508 · DOI
  32. Liu, 2012, Flavokawain A inhibits urinary bladder carcinogenesis in the UPII-SV40T transgenic mouse bladder cancer model, Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 619
  33. Johnson, 2008, Decreased bladder cancer growth in parous mice, Urology, 72, 470, 10.1016/j.urology.2008.04.028 · doi:10.1016/j.urology.2008.04.028
  34. Li, 2012, The role of the androgen receptor in the development and progression of bladder cancer, Jpn J Clin Oncol, 42, 569, 10.1093/jjco/hys072 · DOI
  35. Takimoto, 2002, The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein, Cancer Biol Ther, 1, 47, 10.4161/cbt.1.1.41 · DOI
  36. Xu, 2010, Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis, Cancer Res, 70, 6566, 10.1158/0008-5472.CAN-10-0942 · DOI · Paper page
  37. Roh, 2011, p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma, Oral Oncol, 47, 8, 10.1016/j.oraloncology.2010.10.011 · DOI
  38. Fiorini, 2012, Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis, Apoptosis, 18, 337, 10.1007/s10495-012-0790-6 · DOI
  39. Muret, 2012, Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function, PLoS One, 7, 10.1371/journal.pone.0038808 · DOI
  40. Stein, 1998, Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer, J Natl Cancer Inst, 90, 1072, 10.1093/jnci/90.14.1072 · DOI · Paper page
  41. Hong, 2012, Induction of apoptosis of bladder cancer cells by zinc-citrate compound, Korean J Urol, 53, 800, 10.4111/kju.2012.53.11.800 · DOI
  42. Crew, 1997, Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer, Cancer Res, 57, 5281
  43. Yang, 2004, The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression, Urol Oncol, 22, 1, 10.1016/S1078-1439(03)00015-2 · doi:10.1016/s1078-1439(03)00015-2
  44. Bernardini, 2001, Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer, J Urol, 166, 1275, 10.1016/S0022-5347(05)65752-7 · doi:10.1016/s0022-5347(05)65752-7
  45. Inoue, 2000, Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel, Clin Cancer Res, 6, 2635
  46. Zhang, 2000, Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression, Cancer Res, 60, 3655

Cited by

See all 24

Metadata

Authors
Madka, V., Zhang, Y., Li, Q., Mohammed, A., Sindhwani, P., Lightfoot, S., Wu, X.-R., Kopelovich, L., & Rao, C. V.
Venue
Neoplasia
Publisher
Elsevier BV
Published
2013-08
Volume
15
Issue
8
Pages
966-974
ISSN
1476-5586
DOI
10.1593/neo.13704
Cited by
24
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice. https://app.cochat.ai/papers/10.1593/neo.13704
The paper
Madka, V., Zhang, Y., Li, Q., Mohammed, A., Sindhwani, P., Lightfoot, S., Wu, X.-R., Kopelovich, L., & Rao, C. V. (2013). p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice. Neoplasia. https://doi.org/10.1593/neo.13704

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.